Five PLus Year EffIcacy of Endoscopic Sleeve Gastroplasty (ESG) for Sustained WeigHT Loss
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBoston Scientific Corporation
About this trial
The objective of this study is to assess the long term weight loss and weight loss journey of patients who received an Endoscopic Sleeve Gastroplasty (ESG) 5 or more years prior to enrollment.
Eligibility criteria
Qualifiers
Subject is ≥ 18 years of age at the time of the ESG procedure
Subject with a BMI between 30 kg/m2 and 50 kg/m2, inclusive, at the time of the primary ESG procedure using Overstitch Endoscopic Suturing System
Subject completed follow-up 1-year from the ESG procedure for weight loss management
Subject completed or is eligible for follow-up 5-years from the ESG procedure for weight loss management (visit can be collected either retrospectively or prospectively)
Disqualifiers
None
Trial design
Treatments tested in this trial
- No Intervention: Observational Cohort
Treatment groups
No treatment groups listed
Locations
8Australia
The BMI Clinic2028, Double BayNew South Wales, Australia
France
CHU de Strasbourg, IHU-Strasbourg67000, Strasbourg France
India
Mohak hi-tech Specialty Hospital453555, IndoreMadhya Pradesh, India
Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS00168, Rome Italy
Sponsors and collaborators
Boston Scientific Corporation
Lead sponsor
Source ClinicalTrials.gov